GGHC
Gilder Gagnon Howe & Co Portfolio holdings
AUM
$9.42B
1-Year Return
54.36%
This Quarter Return
+9.24%
1 Year Return
+54.36%
3 Year Return
+272.74%
5 Year Return
+377.85%
10 Year Return
+3,143.71%
AUM
$7.44B
AUM Growth
+$332M
(+4.7%)
Cap. Flow
-$121M
Cap. Flow
% of AUM
-1.63%
Top 10 Holdings %
Top 10 Hldgs %
30.42%
Holding
323
New
41
Increased
71
Reduced
173
Closed
29
Top Buys
| 1 |
Sony
SONY
|
$88.1M |
| 2 |
Five Below
FIVE
|
$70M |
| 3 |
T-Mobile US
TMUS
|
$51.6M |
| 4 |
MongoDB
MDB
|
$37.6M |
| 5 |
Etsy
ETSY
|
$29.5M |
Top Sells
| 1 |
Amazon
AMZN
|
$141M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$56.7M |
| 3 |
Netflix
NFLX
|
$41M |
| 4 |
GIMO
Gigamon Inc.
GIMO
|
$38.6M |
| 5 |
NXTM
NxStage Medical Inc.
NXTM
|
$35.1M |
Sector Composition
| 1 | Technology | 24.2% |
| 2 | Consumer Discretionary | 19.67% |
| 3 | Communication Services | 16.83% |
| 4 | Healthcare | 13.54% |
| 5 | Industrials | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
lululemon athletica
LULU
$19.9B
| $171K | ﹤0.01% |
+2,170
| New | +$171K |
|
|
SQNS
252
Sequans Communications
SQNS
$123M
| $149K | ﹤0.01% |
7,827
-83,978
| -91% | -$1.6M |
|
253
Ubiquiti
UI
$34.9B
| $112K | ﹤0.01% |
1,582
-1,593
| -50% | -$113K |
|
254
Esperion Therapeutics
ESPR
$540M
| $111K | ﹤0.01% |
1,689
| – | – |
|
255
SiriusXM
SIRI
$8.1B
| $101K | ﹤0.01% |
1,883
+96
| +5% | +$5.15K |
|
256
Herc Holdings
HRI
$4.6B
| $94K | ﹤0.01% |
1,507
-512
| -25% | -$31.9K |
|
257
UnitedHealth
UNH
$286B
| $87K | ﹤0.01% |
+396
| New | +$87K |
|
|
NBLX
258
DELISTED
Noble Midstream Partners LP
NBLX
| $60K | ﹤0.01% |
1,207
-51
| -4% | -$2.54K |
|
|
NPTN
259
DELISTED
NEOPHOTONICS CORP
NPTN
| $59K | ﹤0.01% |
8,963
| – | – |
|
260
Berkshire Hathaway Class B
BRK.B
$1.08T
| $43K | ﹤0.01% |
218
+18
| +9% | +$3.55K |
|
261
Banco Macro
BMA
$3.77B
| $37K | ﹤0.01% |
315
-489
| -61% | -$57.4K |
|
|
STDY
262
DELISTED
SteadyMed Ltd
STDY
| $31K | ﹤0.01% |
8,512
-12,984
| -60% | -$47.3K |
|
263
Pacific Biosciences
PACB
$381M
| $23K | ﹤0.01% |
8,659
-14,372
| -62% | -$38.2K |
|
264
Deere & Co
DE
$128B
| $16K | ﹤0.01% |
100
| – | – |
|
265
Voyager Therapeutics
VYGR
$235M
| $15K | ﹤0.01% |
877
-1,340
| -60% | -$22.9K |
|
|
NVRO
266
DELISTED
NEVRO CORP.
NVRO
| – | – |
-1,233
| Closed | -$112K |
|
267
Acadia Healthcare
ACHC
$2.19B
| – | – |
-130,392
| Closed | -$6.23M |
|
268
Alto Ingredients
ALTO
$90.6M
| – | – |
-2,215
| Closed | -$12K |
|
269
Atkore
ATKR
$1.99B
| – | – |
-16,905
| Closed | -$330K |
|
270
Cogent Communications
CCOI
$1.81B
| – | – |
-7,152
| Closed | -$350K |
|
271
Expedia Group
EXPE
$26.6B
| – | – |
-37,116
| Closed | -$5.34M |
|
272
Warrior Met Coal
HCC
$3.19B
| – | – |
-8,674
| Closed | -$204K |
|
273
Itaú Unibanco
ITUB
$76.6B
| – | – |
-498,229
| Closed | -$3.41M |
|
274
Norwegian Cruise Line
NCLH
$11.6B
| – | – |
-12,535
| Closed | -$678K |
|
275
Novavax
NVAX
$1.28B
| – | – |
-1,791
| Closed | -$41K |
|